February 14, 2026 04:19 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rs 5,000 to women ahead of Tamil Nadu polls! Vijay slams Stalin, says: ‘take the money, blow the whistle’ | Modi congratulates Tarique Rahman as BNP clinches majority in Bangladesh polls | Bangladesh Polls: Tarique Rahman-led BNP secures 'absolute majority' with 151 seats in historic comeback | BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers | Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns
Covid-19
NDMC worker sanitises Indian Parliament (Image Credit: UNI)

India adds close to 98,000 Covid-19 cases in 24 hours, tally crosses 51-lakh mark

| @indiablooms | Sep 17, 2020, at 04:10 pm

New Delhi/IBNS: The total number of Novel Coronavirus cases in India on Thursday crossed the 51-lakh mark as the country of 1.3 billion people reported a record spike in Covid-19 cases by adding 97,894 fresh infections in the last 24 hours.

With the new cases, India's Covid-19 tally has touched 51,18,253.

83,198 Covid-19 patients have so far succumbed to the virus with 1,132 people dying from the disease in the last 24 hours.

Meanwhile, the Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, which has been developed by pharmaceutical giant AstraZeneca and Oxford University.

The Oxford vaccine trial was first halted by AstraZeneca after a suspected serious adverse reaction was seen in a participant in the United Kingdom last week.

Following the development, the SII had also halted the vaccine trials in the country.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.